{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T17:24:02Z","timestamp":1792949042997,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,29]],"date-time":"2023-07-29T00:00:00Z","timestamp":1690588800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parasite Epidemiology and Control"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.parepi.2023.e00320","type":"journal-article","created":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T21:24:21Z","timestamp":1690838661000},"page":"e00320","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Evidence-based indications for ivermectin in parasitic diseases: An integrated approach to context and challenges in Peru"],"prefix":"10.1016","volume":"23","author":[{"given":"Virgilio E.","family":"Failoc-Rojas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heber","family":"Silva-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge L.","family":"Magui\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso J.","family":"Rodriguez-Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"D\u00edaz-Velez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moises","family":"Apolaya-Segura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario J.","family":"Valladares-Garrido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parepi.2023.e00320_bb0005","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1186\/1475-2875-13-417","article-title":"Evaluation of ivermectin mass drug administration for malaria transmission control across different west African environments","volume":"13","author":"Alout","year":"2014","journal-title":"Malar. J."},{"issue":"8291","key":"10.1016\/j.parepi.2023.e00320_bb0010","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0140-6736(82)91026-1","article-title":"Efficacy and tolerance of ivermectinin human onchocerciasis","volume":"320","author":"Aziz","year":"1982","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.parepi.2023.e00320_bb0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007858","article-title":"Human myiasis in Ecuador","volume":"14","author":"Calvopina","year":"2020","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"4","key":"10.1016\/j.parepi.2023.e00320_bb0020","first-page":"440","article-title":"Uso de ivermectina en pacientes con la COVID-19: Una revision narrativa","volume":"13","author":"Casta\u00f1eda-Mar\u00edn","year":"2020","journal-title":"Rev. Cuerpo M\u00e9d. Hospit. Nacional Almanzor Aguinaga Asenjo"},{"issue":"2","key":"10.1016\/j.parepi.2023.e00320_bb0025","doi-asserted-by":"crossref","first-page":"382","DOI":"10.4269\/ajtmh.17-0042","article-title":"Serious neurological adverse events after ivermectin\u2014do they occur beyond the indication of onchocerciasis?","volume":"98","author":"Chandler","year":"2018","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"10","key":"10.1016\/j.parepi.2023.e00320_bb0030","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa0905471","article-title":"Oral ivermectin versus malathion lotion for difficult-to-treat head lice","volume":"362","author":"Chosidow","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.parepi.2023.e00320_bb0035","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/bcp.13840","article-title":"Population pharmacokinetics of oral ivermectin in venous plasma and dried blood spots in healthy volunteers","volume":"85","author":"Duthaler","year":"2019","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.parepi.2023.e00320_bb0040","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4269\/ajtmh.16-0437","article-title":"Case report: Myiasis due to Cochliomyia hominivorax and Dermatobia hominis: clinical and pathological differences between two species in northern Peru","volume":"98","author":"Failoc-Rojas","year":"2018","journal-title":"American J. Trop. Med. Hyg."},{"issue":"6","key":"10.1016\/j.parepi.2023.e00320_bb0045","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/QCO.0b013e328010774c","article-title":"Ivermectin: uses and impact 20 years on","volume":"19","author":"Fox","year":"2006","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.parepi.2023.e00320_bb0050","first-page":"2021","article-title":"Nutritional status and associated factors among primary schoolchildren from pastoral communities, Mieso-Mulu District, Sitti Zone, Somali Regional State, Eastern Ethiopia: institution-based cross-sectional study","author":"Geletaw","year":"2021","journal-title":"J. Nutrit. Metabol."},{"issue":"1","key":"10.1016\/j.parepi.2023.e00320_bb0055","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1111\/ijd.14673","article-title":"Topical treatment of cutaneous larva migrans with ivermectin 1%","volume":"59","author":"Gerbig","year":"2020","journal-title":"Int. J. Dermatol."},{"issue":"1","key":"10.1016\/j.parepi.2023.e00320_bb0060","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1208\/s12248-007-9000-9","article-title":"The pharmacokinetics and interactions of ivermectin in humans--a mini-review","volume":"10","author":"Gonz\u00e1lez Canga","year":"2008","journal-title":"AAPS J."},{"issue":"1","key":"10.1016\/j.parepi.2023.e00320_bb0065","first-page":"Cd007745","article-title":"Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection","volume":"2016","author":"Henriquez-Camacho","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"issue":"8","key":"10.1016\/j.parepi.2023.e00320_bb0070","first-page":"563","article-title":"Selective mass treatment with ivermectin to control intestinal helminthiases and parasitic skin diseases in a severely affected population","volume":"82","author":"Heukelbach","year":"2004","journal-title":"Bull. World Health Organ."},{"issue":"1","key":"10.1016\/j.parepi.2023.e00320_bb0075","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13203","article-title":"Efficacy of topical ivermectin and impact on quality of life in patients with papulopustular rosacea: a systematic review and meta-analysis","volume":"33","author":"Husein-ElAhmed","year":"2020","journal-title":"Dermatol. Ther."},{"issue":"1","key":"10.1016\/j.parepi.2023.e00320_bb0080","first-page":"15","article-title":"Parasitosis intestinal en ni\u00f1os atendidos en un establecimiento de salud rural de Cajamarca, Per\u00fa","volume":"4","author":"Ipanaque-Chozo","year":"2018","journal-title":"Rev. Experien. Med. Hospit. Reg. Lambayeque"},{"issue":"3","key":"10.1016\/j.parepi.2023.e00320_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009144","article-title":"A systematic review and an individual patient data meta-analysis of ivermectin use in children weighing less than fifteen kilograms: is it time to reconsider the current contraindication?","volume":"15","author":"Jittamala","year":"2021","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"11","key":"10.1016\/j.parepi.2023.e00320_bb0090","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1086\/374840","article-title":"Review of common therapeutic options in the United States for the treatment of pediculosis capitis","volume":"36","author":"Jones","year":"2003","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.parepi.2023.e00320_bb0095","first-page":"317","article-title":"The multitargeted drug ivermectin: from an antiparasitic agent to a repositioned cancer drug","volume":"8","author":"Juarez","year":"2018","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.parepi.2023.e00320_bb0100","series-title":"FAAP, American Academy of Pediatrics","article-title":"RED BOOK, 2015 Report of the Committee on Infectious Diseases","author":"Kimberlin","year":"2015"},{"key":"10.1016\/j.parepi.2023.e00320_bb0105","article-title":"Capital humano y pobreza regional en Per\u00fa","volume":"31","author":"Le\u00f3n Mendoza","year":"2019","journal-title":"Reg. y Soci."},{"issue":"1","key":"10.1016\/j.parepi.2023.e00320_bb0115","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.1016\/S2214-109X(19)30453-X","article-title":"Safety of oral ivermectin during pregnancy: a systematic review and meta-analysis","volume":"8","author":"Nicolas","year":"2020","journal-title":"Lancet Glob. Health"},{"issue":"4","key":"10.1016\/j.parepi.2023.e00320_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006458","article-title":"Efficacy and safety of co-administered ivermectin plus albendazole for treating soil-transmitted helminths: a systematic review, meta-analysis and individual patient data analysis","volume":"12","author":"Palmeirim","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"4","key":"10.1016\/j.parepi.2023.e00320_bb0125","doi-asserted-by":"crossref","first-page":"ofz019","DOI":"10.1093\/ofid\/ofz019","article-title":"Effect of a single standard dose (150-200 \u03bcg\/kg) of Ivermectin on Loa loa Microfilaremia: systematic review and Meta-analysis","volume":"6","author":"Pion","year":"2019","journal-title":"Open Forum. Infect. Dis."},{"issue":"4","key":"10.1016\/j.parepi.2023.e00320_bb0135","first-page":"Cd012994","article-title":"Ivermectin and permethrin for treating scabies","volume":"4","author":"Rosumeck","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"issue":"6","key":"10.1016\/j.parepi.2023.e00320_bb0140","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1093\/jac\/dkz083","article-title":"Pharmacokinetics of ascending doses of ivermectin in Trichuris trichiura-infected children aged 2\u201312 years","volume":"74","author":"Schulz","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"issue":"3","key":"10.1016\/j.parepi.2023.e00320_bb0145","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/inthealth\/ihaa012","article-title":"Meta-analysis of epilepsy prevalence in West Africa and its relationship with onchocerciasis endemicity and control","volume":"12","author":"Siewe Fodjo","year":"2020","journal-title":"Int. Health"},{"key":"10.1016\/j.parepi.2023.e00320_bb0150","doi-asserted-by":"crossref","first-page":"131","DOI":"10.22354\/in.v22i3.723","article-title":"Caracter\u00edsticas cl\u00ednicas y epidemiol\u00f3gicas de la estrongiloidiasis en un hospital del Norte del Per\u00fa","volume":"22","author":"Silva-D\u00edaz","year":"2018","journal-title":"Infectio"},{"issue":"1","key":"10.1016\/j.parepi.2023.e00320_bb0155","doi-asserted-by":"crossref","first-page":"46","DOI":"10.18683\/germs.2022.1305","article-title":"Self-medication in hospitalized patients with COVID-19: a cross-sectional study in northern Peru","volume":"12","author":"Vasquez-Elera","year":"2022","journal-title":"Germs"},{"key":"10.1016\/j.parepi.2023.e00320_bb0160","first-page":"26","article-title":"Parasitosis intestinal: Helmintos. Prevalencia y an\u00e1lisis de la tendencia de los a\u00f1os 2010 a 2017 en el Per\u00fa","volume":"81","author":"Vidal-Anzardo","year":"2020","journal-title":"Anales de la Facultad de Medicina"}],"container-title":["Parasite Epidemiology and Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405673123000375?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405673123000375?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:41:41Z","timestamp":1762504901000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405673123000375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":30,"alternative-id":["S2405673123000375"],"URL":"https:\/\/doi.org\/10.1016\/j.parepi.2023.e00320","relation":{},"ISSN":["2405-6731"],"issn-type":[{"value":"2405-6731","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evidence-based indications for ivermectin in parasitic diseases: An integrated approach to context and challenges in Peru","name":"articletitle","label":"Article Title"},{"value":"Parasite Epidemiology and Control","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parepi.2023.e00320","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd on behalf of World Federation of Parasitologists.","name":"copyright","label":"Copyright"}],"article-number":"e00320"}}